Combining neural blockade techniques to reduce visceral pain after bariatric surgery
Effect of Combined Paragastric Autonomic Neural Blockade and Laparoscopic Assisted Transversus Abdominis Plane Block on Visceral Pain After Bariatric Surgery
This study is testing a new way to block pain after weight loss surgery to see if it helps reduce discomfort and improve recovery for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 20 Years to 50 Years |
| Sex | All |
| Sponsor | Alexandria University Academic / other |
| Locations | 1 site (Alexandria) |
| Trial ID | NCT06973122 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a combined paragastric autonomic neural blockade and laparoscopic assisted transversus abdominis plane block in managing visceral pain following laparoscopic bariatric surgery. Visceral pain is a significant issue post-surgery, often leading to autonomic symptoms like nausea and vomiting, which are not adequately addressed by traditional pain management methods. The study aims to evaluate how these innovative techniques can alleviate visceral pain and improve patient outcomes during the early postoperative period.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 20-50 with a BMI between 35-50 and classified as ASA physical status class I to III.
Not a fit: Patients with severe cardiac disorders, chronic renal failure, liver cirrhosis, or those with a history of chronic opioid consumption may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce visceral pain and related complications after bariatric surgery, leading to improved recovery and reduced hospital readmissions.
How similar studies have performed: While the approach is innovative, similar studies have shown promise in managing postoperative pain, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 20-50 years, both sexes. * ASA physical status class I to III. * BMI 35- 50 kg/m² Exclusion Criteria: * Severe cardiac disorder * chronic renal failure * liver cirrhosis * allergy to bupivacaine * patients with history of chronic opioid consumption * HBA1C \> 7%
Where this trial is running
Alexandria
- Alexandria University — Alexandria, Egypt (Recruiting)
Study contacts
- Principal investigator: sarah m elgamal, MD — Alexandria University
- Study coordinator: sarah m elgamal, MD
- Email: sarahelgamal1990@yahoo.com
- Phone: 01005496440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.